Non-coding rnas: Uncharted mediators of thyroid cancer pathogenesis

10.3390/cancers12113264Cancers1211Jan-3

Proposing a Generic Model of industrial Policy­ making, with an Emphasis on Electronics Industry

TNA (Technology Needs Assessment), STIP (Scope, Technology, Impact, Policy) & MSTP (Market Stimulating Technology Policy) are three tools and frameworks that can used as policy making model in industry & technology. In this paper we first introduce explain & study them and then we try to present a general model and framework of industrial policy making with attention to pros and cones of the three models above general points of policy making experiences of some successful countries in development of electronics industries and general condition and current situation of electronics industries in Iran. Finally we design a questionnaire that has been filled in by some specialists to be sure about the accuracy of the proposed model

Therapeutic role of curcumin and its novel formulations in gynecological cancers

Gynecological cancers are among the leading causes of cancer-associated mortality worldwide. While the number of cases are rising, current therapeutic approaches are not efficient enough. There are considerable side-effects as well as treatment resistant types. In addition, which all make the treatment complicated for afflicted cases. Therefore, in order to improve efficacy of the treatment process and patients� quality of life, searching for novel adjuvant treatments is highly warranted. Curcumin, a promising natural compound, is endowed with numerous therapeutic potentials including significant anticancer effects. Recently, various investigations have demonstrated the anticancer effects of curcumin and its novel analogues on gynecological cancers. Moreover, novel formulations of curcumin have resulted in further propitious effects. This review discusses these studies and highlights the possible underlying mechanisms of the observed effects. © 2020, The Author(s)

Hippo/MST blocks breast cancer by downregulating WBP2 oncogene expression via miRNA processor Dicer

10.1038/s41419-020-02901-3Cell Death and Disease11866